Amgen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. 

CEO
Robert A. Bradway
CEORobert A. Bradway
Employees
31,500
Employees31,500
Headquarters
Thousand Oaks, California
HeadquartersThousand Oaks, California
Founded
1980
Founded1980
Employees
31,500
Employees31,500

AMGN Key Statistics

Market cap
252.60B
Market cap252.60B
Price-Earnings ratio
27.15
Price-Earnings ratio27.15
Dividend yield
2.12%
Dividend yield2.12%
Average volume
2.96M
Average volume2.96M
High today
$474.00
High today$474.00
Low today
$466.81
Low today$466.81
Open price
$472.06
Open price$472.06
Volume
2.23M
Volume2.23M
52 Week high
$483.99
52 Week high$483.99
52 Week low
$312.39
52 Week low$312.39

Stock Snapshot

As of today, Amgen(AMGN) shares are valued at $468.00. The company's market cap stands at 252.6B, with a P/E ratio of 27.15 and a dividend yield of 2.12%.

On 2026-11-12, Amgen(AMGN) stock moved within a range of $466.81 to $474.00. With shares now at $468.00, the stock is trading +0.3% above its intraday low and -1.3% below the session's peak.

Trading activity shows a volume of 2.23M, compared to an average daily volume of 2.96M.

Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $483.99 and a low of $312.39.

Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $483.99 and a low of $312.39.

AMGN News

Investing.com 9h
Argus raises Amgen stock price target on pipeline strength - Investing.com

...

Argus raises Amgen stock price target on pipeline strength - Investing.com
TipRanks 10h
Amgen price target raised to $515 from $460 at Argus

Argus raised the firm’s price target on Amgen (AMGN) to $515 from $460 and keeps a Buy rating on the shares. The company has a strong pipeline of potential new...

TipRanks 12h
Balanced Outlook on Dazodalibep as Efficacy Strengths Face Safety and Dosing Uncertainties; Price Target Unchanged at $410

Amgen, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Terence Flynn from Morgan Stanley maintained a Hold rating on the st...

Analyst ratings

54%

of 37 ratings
Buy
29.7%
Hold
54.1%
Sell
16.2%

More AMGN News

Simply Wall St 1d
What Does Amgen FDA Warning Mean For Investors?

Amgen (NasdaqGS:AMGN) received an FDA warning letter regarding a Vectibix promotional video that omitted key risk and indication details. The FDA letter cites...

What Does Amgen FDA Warning Mean For Investors?
Benzinga 1d
Amgen Experimental Drug Shows Symptom Reductions in Chronic Autoimmune Disease That Impacts Tears

Amgen Inc. (NASDAQ:AMGN) announced positive Phase 3 results showing dazodalibep significantly reduced systemic disease activity and key symptoms in patients wit...

Amgen Experimental Drug Shows Symptom Reductions in Chronic Autoimmune Disease That Impacts Tears
Seeking Alpha 1d
Amgen slips after late-stage trial data for Sjögren's disease therapy

Amgen (AMGN) shares fell in premarket trading on Wednesday after the California-based pharma giant announced detailed results from a late-stage trial for dazoda...

Amgen slips after late-stage trial data for Sjögren's disease therapy
Investor's Business Daily 1d
Amgen, In A Buy Zone, Unveils Highly Anticipated Novartis-Rivaling Sjogren's Data

Technology Amgen, In A Buy Zone, Unveils Highly Anticipated Novartis-Rivaling Sjogren's Data Licensing After several high-profile setbacks among its competitors...

Amgen, In A Buy Zone, Unveils Highly Anticipated Novartis-Rivaling Sjogren's Data
24/7 Wall St. 2d
Amgen vs. Regeneron: Higher Dividends Now or Bigger Growth Later?

It sounds nuts, but SoFi is giving new Active Invest users up to $1,000 in stock for a limited time, and all it takes is a $50 deposit to get started. See for y...

Amgen vs. Regeneron: Higher Dividends Now or Bigger Growth Later?
Simply Wall St 3d
Is Amgen Expensive On Strong Q3 Results And Pipeline Progress?

Amgen (AMGN) has been in focus after a packed early November. Fresh third quarter figures, new real world Repatha data and progress in obesity and autoimmune pr...

Is Amgen Expensive On Strong Q3 Results And Pipeline Progress?
The Motley Fool 4d
The Top 5 Biotech Stocks I'd Buy Right Now Without Any Hesitation

Biotech stocks have performed well in 2026, but things could change fairly rapidly. The industry is notoriously volatile, after all, and there are significant r...

The Top 5 Biotech Stocks I'd Buy Right Now Without Any Hesitation

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.